IDDI Experience in Orphan Drugs
IDDI, Your partner in Orphan Drugs
International Drug Development Institute (IDDI) has provided Biostatistics and eClinical Services for 38 clinical trials in orphan drugs.
When conducting clinical trials involving rare diseases, sponsors face medical, scientific and operational challenges. Studies in orphan diseases need a CRO with specific strategies regarding site selection, patient enrollment, and retention.
At IDDI, we understand those challenges and have the expertise to help you successfully develop drugs for patients with rare and extremely rare diseases. Check out our experience!
TO ACCESS THE FILE OF OUR TRIALS EXPERIENCE PLEASE FILL OUT THE FORM BELOW